You are here: Industry Insights > lupin

News List

Lupin receives US FDA’s approval for Albendazole Tablets USP expresspharma
June 12, 2020
Albendazole Tablets USP, 200 mg, are an anthelmintic drug indicated for treatment of cystic hydatid disease of multiple organs and Parenchymal neurocysticercosis.
US FDA grants Lupin’s Mexiletine Orphan Drug Designation expresspharma
June 09, 2020
Myotonic disorders are a group of heterogeneous, inherited, neuromuscular disorders characterized by a shared symptom called myotonia.
Lupin and Mylan receive European Marketing Authorization for Nepexto, Biosimilar Etanercept expresspharma
June 05, 2020
A a phase 3 clinical study in patients with moderate-to-severe active rheumatoid arthritis confirmed equivalence of Nepexto to Enbrel in terms of efficacy, safety and immunogenicity.
Lupin signs distribution agreement in EU territories for orphan drug NaMuscla expresspharma
June 04, 2020
Reportedly, NaMuscula is the first and only licensed product for myotonia in adults with non-dystrophic myotonic disorders.
Lupin receives US FDA approval for Meloxicam capsules expresspharma
June 03, 2020
Lupin's Meloxicam capsules are a generic equivalent of Vivlodex Capsules of Zyla Life Sciences US.
Lupin Q4 net profit rises 35 pc to Rs 390 cr expresspharma
June 01, 2020
The company had posted a net profit of Rs 289.56 crore for the corresponding period of the previous fiscal, Lupin said in a late night filing.
Lupin launches authorised generic version of Apriso expresspharma
May 19, 2020
Mesalamine Extended-Release Capsules 0.375 g (the authorized generic version) are indicated for the maintenance of remission of ulcerative colitis in patients 18 years of age and older.
Lupin announces results of Phase 3 study of Single-Dose Solosec for treatment of trichomoniasis expresspharma
May 05, 2020
Primary endpoint successfully achieved in Phase 3 clinical trial of 147 patients.
Lupin Receives Tentative Approval for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL expresspharma
April 30, 2020
Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL, Unit-dose Vials are indicated for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD).
Lupin’s Pithampur Unit-1 facility receives EIR from US FDA expresspharma
April 30, 2020
The inspection for the facility was conducted by the US FDA between February 3, 2020 and February 11, 2020 and concluded with two observations.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page